Treatment of non-muscle invasive bladder cancer with Bacillus Calmette–Guerin (BCG): Biological markers and simulation studies

Intravesical Bacillus Calmette–Guerin (BCG) vaccine is the preferred first line treatment for non-muscle invasive bladder carcinoma (NMIBC) in order to prevent recurrence and progression of cancer. There is ongoing need for the rational selection of i) BCG dose, ii) frequency of BCG administration a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiselyov, Alex, Bunimovich-Mendrazitsky, Svetlana, Startsev, Vladimir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661599/
https://www.ncbi.nlm.nih.gov/pubmed/26673853
http://dx.doi.org/10.1016/j.bbacli.2015.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4661599/
https://www.ncbi.nlm.nih.gov/pubmed/26673853
http://dx.doi.org/10.1016/j.bbacli.2015.06.002

Ejemplares similares